LB Pharmaceuticals (LBRX) grants director 10,000 stock options at $27.95
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
LB Pharmaceuticals director Robert R. Ruffolo received a stock option grant covering 10,000 shares of common stock. The options have an exercise price of $27.95 per share and expire on June 2, 2036.
According to the terms, 100% of the shares underlying the option vest on the earlier of June 3, 2027 or the date of the company’s next annual meeting of stockholders, as long as he remains in continuous service through the vesting date. After this grant, Ruffolo holds 10,000 stock options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
RUFFOLO ROBERT R
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 10,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 10,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 10,000 options
Exercise price: $27.95 per share
Expiration date: June 2, 2036
+2 more
5 metrics
Options granted
10,000 options
Stock Option (Right to Buy) grant to director on June 3, 2026
Exercise price
$27.95 per share
Conversion or exercise price for the stock options
Expiration date
June 2, 2036
Option expiration for 10,000 underlying common shares
Underlying shares
10,000 shares
Common stock underlying the granted options
Post-grant derivative holdings
10,000 options
Total derivative shares following the reported transaction
Key Terms
Stock Option (Right to Buy), underlying security, exercise price, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
underlying security financial
"underlying_security_title: "Common Stock" and underlying_security_shares: "10000.0000""
exercise price financial
"conversion_or_exercise_price: "27.9500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-02T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
continuous service financial
"subject to the Reporting Person's continuous service through such vesting date"
FAQ
What did LB Pharmaceuticals (LBRX) director Robert Ruffolo report on this Form 4?
Robert Ruffolo reported receiving a stock option award for 10,000 shares of LB Pharmaceuticals common stock. The options were granted at a $27.95 exercise price and represent compensation, not an open-market purchase or sale of existing shares.
How many LB Pharmaceuticals (LBRX) options were granted to Robert Ruffolo?
The filing shows a grant of stock options covering 10,000 shares of LB Pharmaceuticals common stock. This entire amount was acquired in a single derivative transaction and is now held directly following the grant.
What is the exercise price of Robert Ruffolo’s LB Pharmaceuticals (LBRX) stock options?
The options have an exercise price of $27.95 per share. This means Ruffolo can buy LB Pharmaceuticals common stock at $27.95 per share upon exercising the options after they vest and before they expire.
When do Robert Ruffolo’s LB Pharmaceuticals (LBRX) options vest?
All 10,000 option shares vest on the earlier of June 3, 2027 or the date of LB Pharmaceuticals’ next annual stockholders’ meeting. Vesting requires Ruffolo’s continuous service with the company through the applicable vesting date.
When do the LB Pharmaceuticals (LBRX) stock options granted to Robert Ruffolo expire?
The options expire on June 2, 2036. Ruffolo must exercise any vested options before this expiration date; after that, any unexercised options will no longer be exercisable under the terms disclosed.